Global Strongyloidiasis Therapeutics Clinical Trials Market H2 2014 Review Research Report

DALLAS, February 26, 2015 /PRNewswire/ --

RnRMarketResearch.com adds "Strongyloidiasis Global Clinical Trials Review, H2, 2014" market research report to its store. This report provides data on the Strongyloidiasis clinical trial scenario.

The clinical trial report "Strongyloidiasis Global Clinical Trials Review, H2, 2014″ provides elemental information and data relating to the clinical trials on Strongyloidiasis. Strongyloidiasis is a parasitic disease and it is caused by infection with Strongyloides stercoralis. Strongyloidiasis is a roundworm that is fairly common in warm, moist areas. Strongyloidiasis is transmitted through direct dissemination of human skin by infective larvae. Many Strongyloides infections are soft and go unnoticed. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

Symptoms & signs of Strongyloidiasis are abdominal pain, cough, diarrhea, rash, red hive, vomiting and weight loss. This infection is rare in the United States. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Strongyloidiasis.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Strongyloidiasis. The report also includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Companies discussed in this clinical trials report include Johnson & Johnson.

This report also includes the clinical trial overview of top institutes and government that includes The National Institute of Allergy and Infectious Diseases, Centers for Disease Control and Prevention, Universidad Nacional de Salta, Centro Malattie Tropicali, Ospedale Sacro Cuore - Don Calabria, Menzies School of Health Research, Mahidol University Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=255047 . (This is a premium report priced at US$2500 for a single user License.)

Scope of Strongyloidiasis Global Clinical Trials Review, H2, 2014 covers: Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each; Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type; Listings of discontinued trials (suspended, withdrawn and terminated).

Reasons to buy 

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Explore more reports on Clinical Trial industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/clinical-trial .

More reports on Clinical Trials:

Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014 

This report provides elemental information and data relating to the clinical trials on Onchocerciasis (River Blindness). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Companies discussed in this Onchocerciasis (River Blindness) clinical trials report include Pfizer Inc., Johnson & Johnson.

Clinical trial overview of top institutes or government includes Liverpool School of Tropical Medicine, Washington University School of Medicine, UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, University of California, San Francisco, The National Institute of Allergy and Infectious Diseases, University Hospitals Case Medical Center, European Commission, Case Western Reserve University, Centers for Disease Control and Prevention, University of Medicine and Dentistry New Jersey. Complete report details @ http://www.rnrmarketresearch.com/onchocerciasis-river-blindness-global-clinical-trials-review-h2-2014-market-report.html .

Wheezing Global Clinical Trials Review, H2, 2014 

This report provides elemental information and data relating to the clinical trials on Wheezing. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Wheezing. Companies and Institutes discussed in this report includes AstraZeneca PLC, Merck & Co., Inc., GlaxoSmithKline plc, Amphastar Pharmaceuticals, Inc., Milton S. Hershey Medical Center, National Hospital Organization Mie National Hospital, University of Massachusetts, Albert Einstein College of Medicine of Yeshiva University, Case Western Reserve University, UMC Utrecht Holding BV, Oregon Health & Science University, Chinese University of Hong Kong, Queen's University, University of Calgary. Complete report details @ http://www.rnrmarketresearch.com/wheezing-global-clinical-trials-review-h2-2014-market-report.html .

Febrile Neutropenia Global Clinical Trials Review, H2, 2014 

This report provides elemental information and data relating to the clinical trials on Febrile Neutropenia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Febrile Neutropenia. Companies discussed in this clinical trials report include BioGeneriX AG, Apotex, Inc., Amgen Inc., Zydus Cadila Healthcare Limited, Sandoz International GmbH, Pfizer Inc., Johnson & Johnson, Hospira, Inc., Dr. Reddy's Laboratories Limited, Coherus BioSciences, Inc. Complete report details @ http://www.rnrmarketresearch.com/febrile-neutropenia-global-clinical-trials-review-h2-2014-market-report.html .

About Us: 

RnRMarketResearch.com is a database of selected syndicated market research reports for global and regional industries including but not limited to life sciences, information technology & telecommunications, consumer goods, food and beverages, energy and power, automotive and transportation, manufacturing and construction, materials and chemicals, public sector as well as business and financial services. We provide 24/7 online and offline support to our customers.

Contact:
Ritesh Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
E-mail: sales@rnrmarketresearch.com